Chelsea Therapeutics International Ltd said U.S. health regulators rejected its hypotension capsule Northera and sought an additional trial to support the efficacy of the drug.
Chelsea Therapeutics International Ltd said U.S. health regulators rejected its hypotension capsule Northera and sought an additional trial to support the efficacy of the drug.